Skip to main content

Management of severe polyuria in idiopathic Fanconi syndrome

Pediatric Nephrology volume 36, pages 3621–3626 (2021)Cite this article

Abstract

Background

Polyuria is a common problem in patients with tubular diseases, especially for those with CKD and high-output Fanconi syndrome. There are currently no guidelines on how to treat debilitating polyuria, in children or adults, and vasopressin is usually not effective.

Case-diagnosis/treatment

A 13-year-old female with idiopathic Fanconi syndrome and an eGFR of 69 mL/min/1.73 m2 was severely affected by polyuria of 5 L per day (voiding at least 11 times during the day and up to 8 times at night), impacting her mood (measured by the RCADS-child) and academic performance at school. In the absence of guidelines and with literature discouraging the use of indomethacin in this condition, we attempted indomethacin treatment at a dose of 2 mg/kg divided in two doses with substantial success. Urine output dropped to 2.5L and this was accompanied by a substantial decrease of her sodium wasting from 24.6 to 7.7 mmol/kg/day. Over the course of 18 months, the patient’s eGFR dropped temporarily to 60 mL/min/1.73 m2 and was 68 mL/min/1.73 m2 at last follow-up. However, a sodium-23 (23Na) MRI of her thigh revealed ongoing moderate sodium decrease in her skin and substantial Na+ decrease in her muscle when compared to age-matched peers with normal kidney function.

Conclusions

Indomethacin may be a safe and effective treatment option for polyuria in idiopathic Fanconi syndrome.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Haycock GB, Al-Dahhan J, Mak RH, Chantler C (1982) Effect of indomethacin on clinical progress and renal function in cystinosis. Arch Dis Child 57:934–939

    CAS  Article  Google Scholar 

  2. Bickel H, Manz F (1989) Hereditary tubular disorders of the Fanconi type and the idiopathic Fanconi syndrome. Prog Clin Biol Res 305:111–135

    CAS  PubMed  Google Scholar 

  3. Bouchireb K, Boyer O, Mansour-Hendili L, Garnier A, Heidet L, Niaudet P, Salomon R, Poussou RV (2014) Fanconi syndrome and severe polyuria: an uncommon clinicobiological presentation of a Gitelman syndrome. BMC Pediatr 14:201

    Article  Google Scholar 

  4. Leslie SW, Sajjad H, Singh S (2021) Nocturia. StatPearls Publishing, Treasure Island, FL. Available from: https://www.ncbi.nlm.nih.gov/books/NBK518987/. Accessed 14 Feb 2021

  5. Bockenhauer D, van’t Hoff W, Dattani M, Lehnhardt A, Subtirelu M, Hildebrandt F, Bichet DG (2010) Secondary nephrogenic diabetes insipidus as a complication of inherited renal diseases. Nephron Physiol 116:p23-29

    CAS  Article  Google Scholar 

  6. Al-Waili NS, Al-Waili TN, Al-Waili AN, Saloom KY (2005) Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories. World J Urol 23:287–294

    CAS  Article  Google Scholar 

  7. Seyberth HW, Koniger SJ, Rascher W, Kuhl PG, Schweer H (1987) Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1:491–497

    CAS  Article  Google Scholar 

  8. Parchoux B, Guibaud P, Louis JJ, Benzoni D, Larbre F (1982) Urinary prostaglandins and effect of indomethacin therapy in cystinosis. Pediatrie 37:19–30

    CAS  PubMed  Google Scholar 

  9. Ebesutani C, Chorpita BF, Higa-McMillan CK, Nakamura BJ, Regan J, Lynch RE (2011) A psychometric analysis of the Revised Child Anxiety and Depression Scales–parent version in a school sample. J Abnorm Child Psychol 39:173–185

    Article  Google Scholar 

  10. Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985

    Article  Google Scholar 

  11. Qirjazi E, Salerno FR, Akbari A, Hur L, Penny J, Scholl T, McIntyre CW (2021) Tissue sodium concentrations in chronic kidney disease and dialysis patients by lower leg sodium-23 magnetic resonance imaging. Nephrol Dial Transplant 36:1234–1243

    Article  Google Scholar 

  12. Lemoine S, Salerno FR, Akbari A, McIntyre CW (2021) Influence of dialysate sodium prescription on skin and muscle sodium concentration. Am J Kidney Dis 78:156–159

    CAS  Article  Google Scholar 

  13. Ehsanullah RS, Page MC, Tildesley G, Wood JR (1988) Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ 297:1017–1021

    CAS  Article  Google Scholar 

  14. Cohen SE, Hooper SR, Javalkar K, Haberman C, Fenton N, Lai H, Mahan JD, Massengill S, Kelly M, Cantu G, Medeiros M, Phillips A, Sawicki G, Wood D, Johnson M, Benton MH, Ferris M (2015) Self-management and transition readiness assessment: concurrent, predictive and discriminant validation of the STARx questionnaire. J Pediatr Nurs 30:668–676

    Article  Google Scholar 

  15. Ammenti A, Grossi A, Bernasconi S (1986) Infantile cystinosis and insulin-dependent diabetes mellitus. Eur J Pediatr 145:548–549

    CAS  Article  Google Scholar 

  16. Usberti M, Pecoraro C, Federico S, Cianciaruso B, Guida B, Romano A, Grumetto L, Carbonaro L (1985) Mechanism of action of indomethacin in tubular defects. Pediatrics 75:501–507

    CAS  PubMed  Google Scholar 

  17. Vaisbich MH, Fujimura MD, Koch VH (2004) Bartter syndrome: benefits and side effects of long-term treatment. Pediatr Nephrol 19:858–863

    Article  Google Scholar 

  18. Reinalter SC, Grone HJ, Konrad M, Seyberth HW, Klaus G (2001) Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies. J Pediatr 139:398–406

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Pediatrics, Schulich School of Medicine and Dentistry, University of Western Ontario, 800 Commissioners Road East, E3-206, Ontario, N6A 5W9, London, Canada

    Guido Filler & Christopher William McIntyre

  2. Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, 800 Commissioners Road East, E3-206, London, Ontario, N6A 5W9, Canada

    Guido Filler & Yun Cong Zhang

  3. Pathology & Laboratory Medicine, Schulich School of Medicine and Dentistry, University of Western Ontario, 800 Commissioners Road East, E3-206, London, Ontario, N6A 5W9, Canada

    Guido Filler & Christopher William McIntyre

  4. Children’s Health Research Institute, University of Western Ontario, 800 Commissioners Road East, E3-206, London, Ontario, N6A 5W9, Canada

    Guido Filler, Rishika Geda & Christopher William McIntyre

  5. Lilibeth Caberto Kidney Clinical Research Unit, London, Ontario, Canada

    Guido Filler, Fabio Salerno & Christopher William McIntyre

  6. Medical Sciences, University of Western Ontario, London, Ontario, Canada

    Rishika Geda

  7. Biophysics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada

    Fabio Salerno & Christopher William McIntyre

  8. Department of Pediatrics, The University of North Carolina At Chapel Hill, Chapel Hill, NC, USA

    Maria E Díaz-González de Ferris

Authors
  1. Guido Filler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rishika Geda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fabio Salerno
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yun Cong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria E Díaz-González de Ferris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christopher William McIntyre
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Guido Filler conceived this project, wrote the drafts, collated the results, made multiple edits, collated all changes, added intellectual content, and approved the final version.

Rishika Geda conducted the literature review, provided major intellectual input into the design of the study, helped with the interpretation of the results, carefully edited and revised the various versions of the manuscript, and approved the final manuscript.

Fabio Salerno performed the sodium-23 (23Na) MRI study, provided major intellectual input into the analysis of the results, carefully edited and revised various versions of the manuscript, and approved the final manuscript.

Yun Cong Zhang provided major intellectual input into the design of the study, helped with the interpretation of the results, carefully edited and revised various versions of the manuscript, and approved the final manuscript.

Christopher William McIntyre provided major intellectual input into the design of the study, facilitated the sodium-23 (23Na) MRI, helped with the interpretation of the results, carefully edited and revised various versions of the manuscript, and approved the final manuscript.

Maria E Díaz-González de Ferris provided major intellectual input into the design of the study, helped with the interpretation of the results, carefully edited and revised various versions of the manuscript, and approved the final manuscript.

All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Guido Filler.

Ethics declarations

Ethics approval

Case reports are ethics-exempt in our institution; however, written informed consent about publication was obtained by the caregivers. The sodium MRI study received full approval from the Research Ethics Board.

Consent to participate

The authors declare that they have obtained consent to participate from the caregiver of the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key points

What is known about this subject Polyuria is a common problem in patients with tubular disorders and nocturia is highly disruptive, leading to a poor quality of life and negative mood outcomes. The mechanism of polyuria in Fanconi syndrome is thought to be caused by solute and water wasting in the tubules, especially sodium (Na+). Indomethacin therapy is an option for treatment of polyuria in children with infantile cystinosis, as it reduces polyuria by decreasing urinary solute delivery (especially Na +). In the past, this therapy was not recommended for the much rarer idiopathic Fanconi syndrome.

What this study adds We report the successful use of indomethacin in an adolescent female with idiopathic Fanconi syndrome associated with the loss of 0.385 Mb in chromosome region 3p12.2 (unknown significance). This patient had chronic kidney disease (CKD) stage II, debilitating nocturia and the need to void 11 times during the day and 8 times at night. The treatment was safe, did not lead to accelerated deterioration of kidney function, and resulted in a significant improvement in urinary frequency/volume, self-reported mood symptomatology (per the RCADS-Child survey), and academic performance. We also demonstrated a substantial reduction of Na+ wasting with indomethacin while the patient’s muscle Na+ concentration remained substantially depleted, suggesting no further role with Na+intake reduction.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Filler, G., Geda, R., Salerno, F. et al. Management of severe polyuria in idiopathic Fanconi syndrome. Pediatr Nephrol 36, 3621–3626 (2021). https://doi.org/10.1007/s00467-021-05213-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-021-05213-6

Keywords

  • Fanconi syndrome; Indomethacin
  • Polyuria
  • Tubular defect; Reduction of free water clearance
  • Sodium-23 (23Na) MRI
  • Academic performance
  • Mood and quality of life